Research Article
Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis
Table 3
Association between concentration, integrity index, CNV index, and clinical characteristics of patients (
) (
, (
, )).
| Characteristics | Concentration (ng/ml) | | Integrity index | | CNV index | |
| Age at diagnosis (years) | | | | | | | ≤50 | | 0.593 | 0.28 (0.12, 0.61) | 0.134 | | 0.310 | >50 | | | 0.21 (0.08, 0.36) | | | | ER/PR/HER2 status at diagnosis | | | | | | | TNBC | | 0.080 | | 0.695 | | 0.533 | HER2+ (any ER/PR) | | | | | | | HER2- (ER or/and PR+) | | | | | | | Tumor size (cm) | | | | | | | ≤2 | | 0.446 | | 0.658 | | 0.226 | >2 | | | | | | | Tumor stage | | | | | | | I/II | 13.76 (8.94, 18.85) | 0.002 | | 0.141 | 1.03 (0.90,1.18) | 0.278 | III/IV | 25.02 (12.67, 35.30) | | | | 1.07 (0.92,1.55) | | Metastatic status | | | | | | | No | 12.72 (9.06, 18.18) | 0.001 | | 0.123 | | 0.090 | Yes | 26.16 (15.25, 42.83) | | | | | | Distant metastatic status | | | | | | | No | 12.94 (9.41, 19.53) | <0.001 | | 0.364 | | 0.008 | Yes | 33.62 (22.95, 41.09) | | | | | |
|
|
|